Screener
GeneDx Holdings WGS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from GeneDx Holdings’s reported figures.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
FAQ
- What is GeneDx Holdings's free cash flow?
- GeneDx Holdings (WGS) reported free cash flow of -$38.86M in Q1 2026.
- How has GeneDx Holdings's free cash flow changed year-over-year?
- GeneDx Holdings's free cash flow decreased by 1058.8% year-over-year, from $4.05M to -$38.86M.
- What is the long-term trend for GeneDx Holdings's free cash flow?
- Over 3 years (2021 to 2024), GeneDx Holdings's free cash flow has grown at a -44.6% compound annual growth rate (CAGR), from -$199.83M to -$33.99M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about GeneDx Holdings's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude